1) Normal sized primary ovary carcinoma syndrome
卵巢上皮癌综合征
2) epithelial ovarian cancer
卵巢上皮癌
1.
Clinical analysis of paclitaxel liposome combined with carboplatin in the treatment of advanced epithelial ovarian cancer;
紫杉醇脂质体联合卡铂治疗晚期卵巢上皮癌的临床分析
2.
Clinical significance of DNA content and cell cycle phase analysis in epithelial ovarian cancer;
卵巢上皮癌DNA含量和细胞增殖水平测定的临床意义
3.
Effect of individual treatment of recarrent epithelial ovarian cancer with ascites
复发性卵巢上皮癌腹水的个体化治疗
3) ovarian epithelial cancer
卵巢上皮癌
1.
The application value of combined detection of serum levels of OPN and CA_(125) in the diagnosis and treatment of ovarian epithelial cancer;
血清骨桥蛋白和CA_(125)联合检测在卵巢上皮癌诊疗中的应用价值
2.
The detection of serum CA125 in patients with ovarian epithelial cancer by chemical luminal immunoassay;
化学发光标记免疫测定法检测卵巢上皮癌患者血清CA125水平
4) Epithelial ovarian carcinoma
卵巢上皮癌
1.
Prognostic factors of epithelial ovarian carcinoma in patients with age under 40;
40岁以下妇女卵巢上皮癌的预后因素
2.
Objective To evaluate the effects of plasma lysophosphatidic acid(LPA)on the carcinogenesis of epithelial ovarian carcinoma and the diagnosis.
目的探讨溶血磷脂酸(lysophosphatidic acid,LPA)在卵巢上皮癌发生和发展中的作用及临床意义。
3.
Thirty-four epithelial ovarian carcinoma (EOC) patients with ascites were divided into two groups: group A (n=22) receiving preoperative chemotherapy with PAC regimen plus abdominal cavity chemotherapy 2 or 3 cycles; group B (n=12) undergoing abdominal chemotherapy only 2 cycels.
卵巢上皮癌伴腹水患者 34例 ,随机分为 2组。
5) ovarian cancer
卵巢上皮癌
1.
Objective To explore the value of serum CA125,CA199 on diagnosis and prognosis in ovarian cancer.
目的探讨血清CA125和CA199检测对卵巢上皮癌的临床价值。
2.
Methods:Protein of nm23 gene was detected by immunohistochemical technique in 45 patients with epithelial ovarian cancer, 12 with borderline, and 10 with benign ovarian tumor.
目的 :探讨nm2 3基因蛋白二磷酸核苷激酶 (NDPK)在卵巢上皮癌中的表达及其临床意义。
3.
Objective:To clone plasminogen activator (uPA) and plasminogen activator inhibitor-1(PAI-1) gene from ovarian cancer tissue and construct the eukaryotic expressive vector for uPA and PAI-1 gene.
目的:克隆人卵巢上皮癌组织uPA和PAI-1基因cDNA全长,构建表达uPA和PAI-1基因的真核表达载体。
6) ovarian carcinoma
卵巢上皮癌
1.
Role of high mobility group A1 small interference RNA in a ovarian carcinoma cell line;
siRNA对卵巢上皮癌细胞HMGA1基因表达抑制的实验研究
补充资料：三倍体综合征和三倍体与二倍体混合体综合征
三倍体综合征和三倍体与二倍体混合体综合征
三倍体指增加一组额外的染色体，约占妊娠的2%。额外的染色体多来自父亲，66%由于两次受精，24%由于所受的精子是二倍体，10%由于受精的卵是二倍体。胎儿大都流产，约为染色体异常自然流产的20%。孕妇可以伴发不同程度的妊高征，胎儿由于胎盘囊性变或细胞遗传学异常而死亡，只有3%的69，XXY存活。偶有三倍体婴儿在妊娠28周后出生，二倍体与三倍体混合体综合征更少见，均有严重的发育缺陷。表现：胎盘大有囊性变。骨骼方面混合体综合征者骨骼生长不对称。颅骨发育不良，后囟门大，眼距过宽，虹膜缺损，甚至小眼。鼻梁低，耳畸形，口颌小。第3、4指并指，通贯掌纹，马蹄内翻畸形足。先天性心脏病(心房和心室间隔缺损)。男性尿道下裂，阴茎小，隐睾，睾丸间质细胞增生。脑异常。肾上腺发育不全，肾畸形。此类综合征胎体大多流产，出生后也会早期死亡。存活的二倍体与三倍体混合体一般都有精神运动障碍。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条